#Needle Free Injection Systems Industry Share

[roshankumar7904800]

Safety Syringes Market

Safety Syringes Market Size, Share, Trends: Becton, Dickinson and Company Lead

Rising adoption of prefilled safety syringes drives market growth

Market Overview:

The Safety Syringes Market is projected to grow at a CAGR of 8.3% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. North America currently dominates the market, with key metrics indicating strong growth in healthcare infrastructure and stringent safety regulations. The market is experiencing significant expansion due to increasing awareness about needlestick injuries, growing prevalence of chronic diseases requiring injectable medications, and technological advancements in syringe design.

DOWNLOAD FREE SAMPLE

Market Trends:

The safety syringe market is shifting significantly towards the usage of prefilled safety syringes. These new gadgets combine the advantages of safety systems with the ease and accuracy of prefilled drugs. Prefilled safety syringes have various benefits, including fewer pharmaceutical errors, enhanced dosage precision, and increased sterility. Healthcare practitioners are quickly recognising the benefits of these devices in reducing the risk of needlestick injuries and speeding up medication administration procedures.

Market Segmentation:

Retractable safety syringes dominate the market, driven by superior safety features and ease of use. The retractable safety syringes sector now dominates the safety syringes industry. This domination is due to the increased safety features provided by retractable syringes, which effectively reduce the danger of needlestick injuries by automatically withdrawing the needle into the syringe barrel after use. Retractable syringes offer more protection to healthcare staff and patients, along with the growing emphasis on occupational safety in healthcare settings.

Market Key Players:

Becton, Dickinson and Company

B. Braun Melsungen AG

Smiths Medical

Terumo Corporation

Retractable Technologies, Inc.

Sol-Millennium Medical, Inc.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[willyskristina]

Disposable Syringes Market

Disposable Syringes Market Size, Share, Trends: Becton, Dickinson and Company (BD) Leads

Shift Towards Safety-Engineered Syringes to Prevent Needlestick Injuries and Reduce Healthcare-Associated Infections

Market Overview:

The Disposable Syringes Market is projected to grow significantly, driven by increasing healthcare expenditure, the rising prevalence of chronic diseases, and growing awareness about infection control. Asia-Pacific stands out as the fastest-growing region, accounting for a substantial share of the global market. This growth is propelled by the region's vast population base, rising healthcare spending, and increased awareness of safe injection techniques.

The market is experiencing a considerable shift towards safety-engineered syringes, with built-in safety features to prevent needlestick injuries and limit the danger of bloodborne pathogen transmission. This trend is further fueled by severe rules in many countries that require the use of safety equipment in healthcare settings. 

DOWNLOAD FREE SAMPLE

Market Trends:

The disposable syringe market is witnessing a significant shift towards safety-engineered syringes. These modern gadgets include built-in safety features to avoid needlestick injuries and limit the danger of bloodborne pathogen transmission. According to research analysis, safety syringes can reduce needlestick injuries by up to 80% compared to traditional syringes. This tendency is further driven by stringent regulations in many countries that require the use of safety devices in healthcare settings.

Market Segmentation:

Safety syringes dominate the disposable syringes market, accounting for a significant share of the market. This dominance is linked to a growing emphasis on healthcare worker safety and strict regulations requiring the use of safety devices in medical environments. Safety syringes, which include features such as retractable needles and protective covers, have demonstrated exceptional success in preventing needlestick injuries. A recent study found that implementing safety syringes in a large hospital system reduced percutaneous injuries among healthcare workers by 74% over a five-year period.

The long-term cost-effectiveness of safety syringes drives the segment's expansion further. While initially more expensive than traditional syringes, safety devices greatly lower the expenses of needlestick injuries, such as testing, treatment, and lost productivity. Technological breakthroughs in safety syringe design have increased user acceptance and patient satisfaction, leading to higher compliance rates and enhanced safety in healthcare settings.

Market Key Players:

Prominent players in the disposable syringes market include Becton, Dickinson and Company (BD), Terumo Corporation, B. Braun Melsungen AG, Smiths Medical, Nipro Corporation, Hindustan Syringes & Medical Devices Ltd., Cardinal Health, Retractable Technologies, Inc., Gerresheimer AG, and Schott AG. These companies are leading the market with their innovative approaches, extensive product portfolios, and robust distribution networks, continuously setting industry standards and driving market growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[amrutatbrc1]

Subcutaneous Drug Delivery Devices Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033

The subcutaneous drug delivery devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Subcutaneous Drug Delivery Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $25.78 billion in 2023 to $27.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, growing demand for self-administration of drugs, the rise in diabetes and obesity rates, patient preference for convenient treatments, and the rising geriatric population. The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $36.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growth in the biologics and biosimilars market, rising adoption of wearable drug delivery systems, expansion of personalized medicine, improving healthcare reimbursement policies, and growing emphasis on home healthcare. Major trends in the forecast period include the integration of digital health technologies, the development of smart and connected devices, the rise of minimally invasive procedures, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The increasing prevalence of diabetes and cardiovascular diseases (CVD) is expected to propel the growth of the subcutaneous drug delivery devices market going forward. The rising prevalence of diabetes and cardiovascular diseases is driven by aging populations, unhealthy diets, sedentary lifestyles, obesity, socioeconomic inequalities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices are used in diabetes to administer insulin and other medications for glycemic control and in cardiovascular diseases to provide drugs such as anticoagulants or lipid-lowering agents, offering a convenient and controlled method for managing these chronic conditions. For instance, in April 2023, according to the British Diabetic Association, a UK-based charity for people living with diabetes, new data reveals that 4.3 million people in the UK are currently living with a diabetes diagnosis. The number of registered cases for 2021-22 has increased by 148,951 compared to 2020-21, with over 2.4 million individuals at high risk of developing type 2 diabetes in the UK. Additionally in May 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, in 2022, heart disease claimed the lives of 702,880 people, accounting for 1 in every 5 deaths. Therefore, the increasing prevalence of diabetes and cardiovascular diseases (CVD) is driving growth in the subcutaneous drug delivery devices market.

Market Trends - Major companies operating in the subcutaneous drug delivery devices market are focusing on the development of innovative products, such as miniature digital liquid flow sensors, to enhance the safety and precision of subcutaneous drug delivery by providing accurate, customizable flow sensors for large-volume injectors. Miniature digital liquid flow sensors are compact devices that precisely measure the flow rate of liquids in small-scale applications, providing digital output for accurate monitoring and control. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, launched the SLD3x series sensor platform. This sensor series features highly accurate digital liquid flow sensors with customizable solutions, offering precise flow measurement, occlusion detection, in-line air bubble identification, and liquid temperature monitoring. These miniature sensors are ideal for large-scale medical device manufacturing, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.

The subcutaneous drug delivery devices market covered in this report is segmented –

1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps 2) By Application: Diabetes, Fertility, Oncology 3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers

Get an inside scoop of the subcutaneous drug delivery devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp

Regional Insights - North America was the largest region in the subcutaneous drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

Table of Contents 1. Executive Summary 2. Subcutaneous Drug Delivery Devices Market Report Structure 3. Subcutaneous Drug Delivery Devices Market Trends And Strategies 4. Subcutaneous Drug Delivery Devices Market – Macro Economic Scenario 5. Subcutaneous Drug Delivery Devices Market Size And Growth ….. 27. Subcutaneous Drug Delivery Devices Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[credenceresearchdotblog]

The Vial Adaptors for Reconstitution Drug Market is experiencing robust growth, underscored by significant financial metrics and projections. As of 2023, the market is valued at USD 2,186.69 million. This dynamic sector is anticipated to reach a market size of USD 4,146.27 million by 2032, driven by a compound annual growth rate (CAGR) of 7.24% over the forecast period from 2024 to 2032. The global vial adaptors for reconstitution drug market has witnessed significant growth over the past few years, driven by the rising demand for advanced drug delivery systems, increasing prevalence of chronic diseases, and the growing need for efficient and safe drug administration methods. Vial adaptors are critical components in the pharmaceutical industry, facilitating the transfer of drugs from vials to syringes without compromising sterility. They play a crucial role in the reconstitution of lyophilized drugs, which are widely used in various therapeutic areas, including oncology, infectious diseases, and autoimmune disorders.

Browse the full report at https://www.credenceresearch.com/report/vial-adaptors-for-reconstitution-drug-market

Market Overview

The vial adaptors for reconstitution drug market is characterized by the presence of several key players, including global pharmaceutical and medical device companies. The market is segmented based on type, application, end-user, and region. The types of vial adaptors include multi-use and single-use adaptors, with single-use adaptors dominating the market due to their cost-effectiveness and reduced risk of cross-contamination. Applications of vial adaptors span across hospital pharmacies, retail pharmacies, and homecare settings, with hospital pharmacies holding a significant share of the market due to the high volume of drug administration in these settings.

Drivers of Market Growth

1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has led to an increased demand for injectable drugs, many of which require reconstitution before administration. Vial adaptors provide a safe and efficient way to reconstitute these drugs, thereby driving the growth of the market.

2. Technological Advancements: Innovations in vial adaptor design, such as the development of needle-free systems, have enhanced the safety and ease of drug reconstitution. These advancements reduce the risk of needlestick injuries and improve the overall user experience, contributing to the market's expansion.

3. Growing Geriatric Population: The global aging population is another significant factor fueling the demand for vial adaptors. Older adults are more likely to suffer from chronic conditions that require regular medication, often in injectable form. Vial adaptors simplify the process of drug reconstitution and administration, making them an essential tool in managing the health of the elderly.

4. Rising Awareness of Infection Control: In the wake of the COVID-19 pandemic, there has been an increased emphasis on infection control in healthcare settings. Vial adaptors help minimize the risk of contamination during drug reconstitution, making them a preferred choice among healthcare providers.

Regional Insights

The global vial adaptors for reconstitution drug market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the market, driven by a well-established healthcare infrastructure, high healthcare expenditure, and the presence of major pharmaceutical companies. Europe follows closely, with significant contributions from countries like Germany, the UK, and France.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. This growth is attributed to increasing healthcare investments, rising awareness about advanced drug delivery systems, and the growing burden of chronic diseases in countries such as China and India. The expanding pharmaceutical industry in these regions also contributes to the market's growth.

Challenges and Restraints

Despite the positive growth trajectory, the vial adaptors for reconstitution drug market faces several challenges. One of the primary challenges is the high cost associated with advanced vial adaptors, which may limit their adoption, particularly in developing regions. Additionally, the availability of alternative drug delivery methods, such as pre-filled syringes, could pose a threat to the market's growth.

Another challenge is the stringent regulatory environment governing the approval of medical devices and drug delivery systems. Manufacturers must comply with various regulatory requirements, which can be time-consuming and costly.

Future Prospects

The future of the vial adaptors for reconstitution drug market looks promising, with continued advancements in technology and increasing demand for safe and efficient drug administration methods. Companies are likely to focus on developing cost-effective, user-friendly, and environmentally sustainable adaptors to meet the evolving needs of healthcare providers and patients.

Furthermore, the market is expected to benefit from the growing trend of home-based healthcare, where patients require easy-to-use devices for self-administration of medications. This trend is particularly relevant in the context of chronic disease management, where long-term treatment is often necessary.

Key players

Braun Melsungen AG

Becton, Dickinson and Company

Baxter International

Miltenyi Biotec

West Pharmaceutical Services Inc.

Hanna Equipments (India) Pvt. Ltd.

Helapet Ltd

MedXL Inc.

Yukon Medical

Vygon SA

Parasol Medical, LLC

Stevanato Group

Segments

Based on Type

20 mm Vial Adaptor

Others

Based on Therapeutic Area

Infectious Diseases

Autoimmune Diseases

Metabolic Conditions

Reproductive Health

Others

Based on End User

Hospitals

Clinics

Others

Based on Material

Polycarbonate

Silicon

PET Glycol

Polyethylene

Others

Based on Delivery Mode

Injection

Infusion

Others

Browse the full report at https://www.credenceresearch.com/report/vial-adaptors-for-reconstitution-drug-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[foodagriculturenews]

Precision Swine Farming Market Share, Analysis | Industry Growth Report

The precision swine farming market is projected to reach USD 711 million by 2028 from USD 418 million by 2023, at a CAGR of 11.2% during the forecast period in terms of value.

The market for precision swine farming by software offering is experiencing growth due to the need for efficient data management and analysis in managing a large number of pigs as there has been a surge in demand for pork products. The demand for needle-free injection systems by hardware offering drives the market due to the reduced risk of infection. Swine identification and tracking systems are increasingly in demand in the precision swine farming market.

Download PDF Brochure

The precision swine farming market is experiencing an increasing demand for needle-free injection systems. This can be attributed to the numerous advantages they offer, such as the reduction of infection risk and improved animal welfare.

The use of needle-free injection systems can significantly reduce the risk of infection for both animals and workers by eliminating the possibility of needlestick injuries. This, in turn, can ensure the safety and health of livestock, while also safeguarding the health of workers. Moreover, needle-free injection systems also offer an array of benefits in terms of animal welfare. Traditional injection methods can be painful and stressful for animals, leading to a decrease in productivity. Needle-free injection systems alleviate the pain and stress associated with traditional injection methods, thereby ensuring the well-being of livestock.

Swine identification and tracking systems are increasingly in demand in the precision swine farming market. The technology provides crucial data for farmers to monitor individual pigs, optimize growth, and track their health status. With information on each pig's feed intake, weight gain, and behavior, farmers can adjust their management practices to ensure that every pig receives the appropriate level of care, improving efficiency and yield.

This technology also helps prevent disease outbreaks by quickly identifying and isolating sick pigs, reducing the risk of spreading disease to healthy ones and minimizing the need for antibiotics. Swine identification and tracking systems also aid farmers in complying with regulatory requirements related to food safety and animal welfare. By keeping accurate records of pig movement, feed intake, and medication history, farmers can demonstrate their adherence to regulatory authorities, increasing credibility and avoiding penalties.

Make an Inquiry

Europe holds the largest share in the precision swine farming market due to several factors, including a shortage of labor and an aging population, as well as a growing focus on sustainable pork production and an increasing demand for efficiency and productivity in swine farming. In response to the labor shortage and aging population, European farmers have been investing in precision farming technologies, which help to increase efficiency and productivity while reducing the need for manual labor.

The key players in this market include Nedap N.V. (Netherlands), CTB, Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim Animal Health USA Inc. (US), Guangzhou Yingzi Technology Co, Ltd. (China), Hotraco (Netherlands), VDL Agrotech BV (Netherlands), AcuShot Needle Free (Canada), Pulse NeedleFree Systems (US), Henke Sass Wolf GmbH (Germany), Big Dutchman (Germany), EN-CO Software Zrt (Hungary), Luda Farm AB (Sweden), AGCO Corporation (US) and Microfan (Netherlands).

[shivt123]

Data Bridge Market Research analyses that the needle free injection systems market growing at a CAGR of 15.46% in the forecast period of 2022-2029. 

[ken-research-market-research]

Transformation Insights On Needle-Free Drug Delivery Systems Global Market Outlook: Ken Research The spreading base of the diabetic patients and augmenting ease in the admittance to type 1 diabetes are likely to encourage the growth of the market during the review duration.

[engineeringtechnique]

SOLIDWORKS Simulation for Medical Device Industry

Medical Device Industry has been in news from the last 5 months due to obvious reasons and its due to COVID-19. But the Medical device industry is here to stay, Market drivers for medical device growth include a greying population, steady economic growth in emerging markets, and innovative approaches to diagnostics and latest medical innovations, due to this the use of various medical devices has witnessed a drastic increase in their sales.

What is SOLIDWORKS Simulation? 

For the Product engineers who use SOLIDWORKS software to design Medical Device, the testing during each stage of product development is crucial to understanding how products will work and whether they will behave as desired. SOLIDWORKS Simulation design validation solutions enable SOLIDWORKS Product Engineers and users to perform a variety of simulations and leverage CAD data for different engineering purposes during all phases of the design process.

PROVEN SIMULATION SOLUTION

SOLIDWORKS Simulation has virtual testing capabilities which are built on a strong finite element analysis (FEA) foundation.

The complete integration between SOLIDWORKS Simulation and SOLIDWORKS 3D CAD offers multiple benefits for the medical engineer:

100 per cent collaboration between the design     model and simulation model so any design changes and variations are     automatically updated on the simulation model for “what if” scenarios.

Excellent data (3D CAD) support: The design     properties become engineering properties for a productive and trouble-free     workflow such as fasteners, automatic recognition of fluid domain in CFD     materials properties, and recognition of the geometry topology for mesh     definition.

Shared communication tool with eDrawings     allows simulation results to be easily communicated downstream with all     stakeholders of the project.

SOLIDWORKS Simulation, together with the CFD capabilities in SOLIDWORKS Flow Simulation, the plastic injection moulding tools with SOLIDWORKS Plastics, the sustainability features in SOLIDWORKS Sustainability, and the rigid body motion simulation of SOLIDWORKS Motion have helped users test such medical products as cardiovascular stents, heart valve replacements, orthopaedic implants, blood pressure monitors, anaesthetic units, cancer treatment delivery systems, solution pumps, open oxygen delivery systems, centrifugal blood separators, needle-free drug delivery systems, and many more. 

For any Commercial Inquiries or a Free Demo of SOLIDWORKS please call on 09427611239 or mail to marketing@enggtechnique.com. Engineering Technique is an Value Added Reseller of SOLIDWORKS.

[rootsanalysis-blog]

The global autoinjectors market is projected to grow at an annualized rate of over 10%

Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients

 Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”

 The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of autoinjectors over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of developers engaged in the development and / or manufacturing autoinjectors. 

§  A detailed assessment of current landscape of companies that are developing drugs in combination with autoinjectors.

§  A competitiveness analysis of various disposable and reusable autoinjectors.

§  A detailed brand positioning analysis of leading industry players highlighting the current perceptions regarding their proprietary brands.

§  A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with autoinjectors in the near future.

§  A list of key opinion leaders (KOLs) within this domain with significant contributions in clinical trials and filing patent applications.

§  Detailed case studies on the most commonly targeted indications of the approved autoinjector products.

§  A case study on the role of CMOs offering services for drug delivery devices.

§  A SWOT analysis capturing the key parameters and trends that are likely to influence the future of autoinjectors market.

§  Elaborate profiles of autoinjector manufacturers that have more than three devices in their respective product portfolios.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Usability 

§  Disposable

§  Reusable

Route     of Administration

§  Subcutaneous

§  Intramuscular

Type     of Molecule

§  Monoclonal Antibody

§  Peptide

§  Protein

§  Small Molecule

Therapeutic     Indication

§  Anaphylaxis

§  Asthma

§  Multiple Sclerosis

§  Rheumatoid Arthritis

§  Migraine

§  Diabetes

§  Other Indications

Key     Geographies

§  North America

§  Europe

§  Asia-Pacific

§  Rest of the World

 The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The opinions and insights presented in the report were influenced by discussions held with several players in this industry. The study includes detailed transcripts of discussions held with the following individuals:

§  David Daily (CEO and Co-founder, DALI Medical Devices)

§  Dennis Lee (Senior Program Officer in CMC, Bill & Melinda Gates Foundation)

§  Douglas Marenzi (Managing Director, PHC Injection Technologies)

§  Tsachi Shaked (Senior Marketing and BD Director, Injectable Drug Delivery Devices, Elcam Medical)

§  Jesse Fourt (Design Director, IDEO)

 Key companies covered in the report

§  Antares Pharma

§  Consort Medical (Previously Bespak)

§  DALI Medical Devices

§  Elcam Medical (E3D Elcam Drug Delivery Devices)

§  Jiangsu Delfu Medical Devices

§  Oval Medical Technologies

§  Owen Mumford

§  SHL Group

§  Union Medico®

§  Ypsomed

 For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 Other Recent Offerings

1.     Prefilled Syringes Market (5th Edition), 2019-2030

2.     Novel Vaccine Delivery Devices Market, 2019-2030

3.     Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

 About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

[rootsanalysis]

The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

 Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”.

 The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:

§  A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.

§  A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.

§  An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.

§  A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.

§  Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.

§  A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Global     Novel Vaccine Delivery Devices (By Value)  

§  Type of Device

§  Electroporation-based Needle Free Injection Systems

§  Oral Delivery Systems

§  Nasal Delivery Systems

§  Jet Injectors

§  Microneedle Patches

§  Microinjectors

 §  Route of Administration

§  Oral

§  Intramuscular

§  Intranasal

§  Intradermal

§  Subcutaneous

 §  Type of Vaccines

§  Bivalent Oral Polio Vaccine

§  BCG Vaccine

§  DTP-HepB-Hib Vaccine

§  Pneumococcal Conjugate Vaccine

§  Influenza Vaccine

§  Measles Vaccine

§  Tetanus-Diphtheria Vaccine

§  Others

 §  Key Geographical Region

 North      America

 Europe

 Asia      Pacific

 Rest      of the World

 Key companies covered in the report

§  3M

§  Becton Dickinson

§  Consort Medical

§  D’Antonio Consultants International

§  Enesi Pharma

§  Ichor Medical

§  Iconovo

§  Inovio Pharmaceuticals

§  PharmaJet

§  Union Medico

 For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com

 You may also be interested in the following titles:

1.      Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

2.      Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

3.      Large Volume Wearable Injectors Market (4th Edition), 2018-2030

4.      Global Autoinjectors Market (2nd Edition), 2018-2030

 About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

[healthcaremreports]

The Needle-free Injection Systems market report is provided here in USD Million. The report will render insightful data related to growth rates represented in terms of CAGR % during the projected years.

[healthcareresearchboom]

Needle-Free Injection System Market Size, Growth Drivers & Forecast 2026

The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2020 to 2026. Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases. With the rising geriatric population and the increasing prevalence of chronic diseases, the patient volume has increased significantly globally. This, in turn, is creating a greater demand for advanced and effective treatment approaches, including the use of needle-free injection systems. Moreover, the high adoption of advanced drug delivery technologies across the globe is supporting the growth of this market. On the other hand, limitations with large volume and intravenous administration systems are the key factors restraining the growth of the market.

Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

In this report, the needle-free injection system market is segmented on the basis of product, type, application, technology, site of delivery, end user, and region.

North America accounted segment accounted for the largest share in the needle-free injection system market.

On the basis of region, the needle-free injection system market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable devices testing are supporting market growth in the APAC region.

Fillable needle-free injectors segment accounted for the largest share in the needle-free injection system market.

Based on product, the needle-free injection system market is segmented into fillable and pre-filled needle-free injectors. In 2020, the fillable needle-free injectors accounted for the larger share of 63.4% of the needle-free injection system market. This product segment is projected to reach USD 179.7 million by 2026 from 79.4 million in 2021, at a CAGR of 17.7 % during the forecast period. The large share of this segment can be attributed to the increasing application of needle-free injections in vaccination, insulin, and other drug delivery.

Jet-based needle-free injectors segment accounted for the largest share in the needle-free injection system market.

On the basis of technology, the needle-free injection system market can be segmented into jet-based, spring-based, microarray patches and other injectors. In 2020, the jet-based needle-free injectors segment is expected to command the largest share of 67.4% of the global needle-free injection system devices market by technology. This segment is projected to reach USD 196.9 million by 2026 from USD 71.4 million in 2020, at a CAGR of 18.3% during the forecast period. The large share of this segment can be attributed to benefits associated with this technology, including rapid drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.

liquid-based injectors segment accounted for the largest share in the needle-free injection system market.

Based on the type, the needle-free injection system market is segmented into liquid-based, powder-based and projectile/depot-based needle-free injectors. The liquid-based segment accounted for the largest share of 70.9% of the needle-free injection system market in 2020. The large share of this segment can be attributed to the ability of a liquid jet, which is stronger enough to penetrate the skin and the underlying fat layer without harming the skin or the integrity of the drug molecule.

Subcutaneous injectors segment accounted for the largest share in the needle-free injection system market.

Based on site of delivery, the needle-free injection system market is segmented into subcutaneous, intramuscular and intradermal. In 2020, the subcutaneous injectors segment is estimated to account for the largest share of 48% of the needle-free injection system market by the site of delivery. The higher growth of this segment is due to its greater effectiveness as the drug moves into the capillaries when it is injected and from there, it is carried to the bloodstream.

Fillable segment accounted for the largest share in the needle-free injection system market.

Based on applications, the needle-free injection system market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and other applications. In 2020, vaccine delivery is estimated to account for the largest share of 32.8% of the needle-free injection system market by application. The rising prevalence of chronic diseases and infectious diseases worldwide has increased the demand for vaccination in the considered year and the increasing demand for patient-centric care are the major factors driving the growth of the needle-free injection market by application.

Hospitals & clinics segment accounted for the largest share in the needle-free injection system market.

Based on end users, the needle-free injection market is segmented into hospitals & clinics, home care settings, research laboratories, pharmaceutical and biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 61.0% in 2020. Factors such as technological advancements and an increase in demand for vaccination are driving the growth of the hospitals & clinics segment.

Key Market Players :

The prominent players in global needle-free injection market include PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), and Bioject Medical Technologies (US).

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Don’t miss out on business opportunities in Needle-Free Injection System Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[healthcaredbmrnews]

Needle Free Injection Systems Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2029

Needle Free Injection Systems Market Research Report gives insightful analysis of the market along with its comprehensive understanding and its commercial landscape. The report offers market share appraisals for regional and global levels. It gives detailed overview of the parent market. The report contains information about key drivers, restraints, opportunities, and their impact analysis on the market size.

Data Bridge Market Research analyses that the needle free injection systems market growing at a CAGR of 15.46% in the forecast period of 2022-2029. The widespread presence of chronic diseases and increasing rate of communicable diseases is driving the growth of the needle free injection systems market.

Traditionally, drugs are administered to humans via needles and injections. However, a new concept, needle free injection technology (NFIT), has recently been introduced into the market, which includes a wide range of drug delivery systems. Drugs are delivered through the skin using forces such as shock waves, gas pressure, or electrophoresis. This technique or force propels the drug through the skin, eliminating the need for a hypodermic needle.

Get Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-needle-free-injection-systems-market

Needle free injection systems market is segmented on the basis of type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on type, the needle free injection systems market is segmented into liquid-based needle-free injectors, projectile/depot-based needle-free injectors, and powder-based needle free injectors.

Needle free injection systems market has also been segmented based on the product into fillable needle-free injectors and prefilled needle-free injectors.

On the basis of technology, the needle free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors and vibration-based needle-free injectors.

On the basis of usability, the needle free injection systems market is segmented into disposable needle-free injectors and reusable needle-free injectors.

On the basis of site of delivery, the needle free injection systems market is segmented into subcutaneous injectors, intramuscular injectors and intradermal injectors.

Based on application, the needle free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, and pain management and other.

On the basis of end user, the needle free injection systems market is segmented into hospitals and clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other.

Global  Needle Free Injection Systems Market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Needle Free Injection Systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Get understand insight full study @ https://www.databridgemarketresearch.com/reports/global-needle-free-injection-systems-market

Table of Content:

1 Introduction

2 Market Segmentation

3 Executive Summary

4 Premium Insights

5 Regulatory Scenario

6 Covid-19 Impact On Global  Needle Free Injection Systems Market

7 Global  Needle Free Injection Systems Market, By Service Type

8 Global  Needle Free Injection Systems Market, By Service Providers

9 Global  Needle Free Injection Systems Market, By Device Type

10 Global  Needle Free Injection Systems Market, By Level of Maintenance

11 Global  Needle Free Injection Systems Market, By End User

13 Global  Needle Free Injection Systems Market: Company Landscape

14 SWOT Analysis

15 Company Profile

16 Questionnaire

17 Related Reports

Get Detailed Tables of Contents with Respective images and Pie chart of This Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-needle-free-injection-systems-market

Ome of the major players operating in the needle free injection systems market are Antares Pharma, Endo Pharmaceuticals Inc., Bioject Medical Technologies Inc., Medical International Technology, Inc., INJEX Pharma AG, National Medical Products Co. Ltd., Valeritas, Inc., InsuJet, PenJet, Crossject, Portal Instruments, Amico Group, BD, InsuJet, Glide Pharmaceutical Technologies Limited, Inovio Pharmaceuticals, Inc., MedImmune, Mystic Pharmaceuticals, OptiNose US, Zogenix, Inc and D'Antonio Consultants International, Inc. among others.

 Key Offerings:  Needle Free Injection Systems Market

 Needle Free Injection Systems Market Size & Forecast by Revenue |

 Needle Free Injection Systems Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

 Needle Free Injection Systems Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography

Competitive Landscape – Top key vendors and other prominent vendors

Browse Related Reports@

 Care Management Solutions Market           

 Electronic Clinical Outcome Assessment (eCOA) Market   

 Fitness App Market   

 Healthcare Interoperability Solutions Market                     

 Laboratory Information Management Systems Market      

 Lithotripsy Devices Market   

 Long Term Care Software Market   

 Micro-Invasive Glaucoma Implants Market 

 Molecular Diagnostics Market         

Neuroendoscopy Market